Our History


Historical Highlights

  • Establishment of Lavipharm, a company by the Lavidas’ family.

  • Launch of Digitaline, an innovative cardiovascular product, in Greece.

  • Launch of Nitroglycerin Controlled Release tablets, in Greece.

  • New era begins under the management of Dr. A. Lavidas.

  • Collaboration with L'Oréal - first to sell cosmetics through pharmacies, in Greece.

  • Inauguration of Plant for the production of drugs & cosmetics.

  • Establishment of R&D department focused on drug delivery technologies.

  • First international operation center established in Paris.

  • First to launch AVON products in Greece establishing door-to-door channel.

  • Joint Ventures with Synthélabo and L'Oréal Cosmetique Active Completion of a dedicated transdermal systems production unit in Greece Launch of proprietary dermocosmetic brand CASTALIA.

  • Establishment of state-of-the-art wholesaling and distribution center.

  • Listing on the Athens Stock Exchange First entrance in the international market, launch of proprietary nitroglycerin transdermal system in Italy and France CASTALIA dermocosmetic brand launched internationally.

  • Acquisition of US-based R&D unit specialized in TDDS Launch of patented acne epidermal patch, worldwide, by L'Oréal.

  • Exclusive licensing rights to manufacture and market Betadine® brand in Greece.

  • Acquisition of R&D companies (France and the USA) with expertise in SCF technologies.

  • Establishment of a new subsidiary, Pharma PLUS, focusing on creating a nationwide pharmacy network under a common brand.

  • FDA approval of proprietary fentanyl patch.

  • Fentanyl patch first launch in Greece.

  • Fentanyl patch launch in Germany.

  • Regulatory approval to market fentanyl patch in 20 countries.

  • Establishment of operation center in Italy.

  • Entry in the Urology Market in Greece.

  • Entry in the Rare Diseases’ market.

  • Manufacturing rights for rivastigmine patch.

  • Technology transfer for clonidine patch.

  • Exclusive distribution agreement with Zentiva in Greece.

  • Telemaque Lavidas takes helm of Lavipharm Group.
    Lavipharm is celebrating 110 Years Innovation in Health.

    Fentanyl patch consecutive launches in the EU, Latin America and Asia.

  • Acquisition of rights for clonidine patch.

    Strategic alliance with Tikun Europe. Olam

  • Direct commercial activities for clonidine patch in Italy.

    Launch of Lifelab CBD in Greece.